WEBULL
News
MAYNF
2.110
NaN%
--
Mayne Pharma Showcases DistributeRx U.S. Launch in Investor Briefing
TipRanks · 3d ago
Mayne Pharma launches DistributeRx to drive direct-to-patient U.S. growth
TipRanks · 4d ago
Mitsubishi UFJ Financial Group exits substantial holder position in Mayne Pharma
TipRanks · 03/02 08:56
Mayne Pharma Discloses Exit of Director Patrick Blake and His Share Interests
TipRanks · 03/02 03:53
First Sentier Group Exits Substantial Shareholding in Mayne Pharma
TipRanks · 02/27 09:06
Mayne Pharma Earnings Call Balances Growth And Risk
TipRanks · 02/24 00:11
Mayne Pharma Plans New Performance Rights Issue
TipRanks · 02/23 08:09
Mayne Pharma Discloses Equity Holdings as Director Shawn O’Brien Departs Board
TipRanks · 02/23 08:07
Mayne Pharma Frames 1H FY26 Results Around EBITDA and Disclosure Transparency
TipRanks · 02/22 23:30
Mayne Pharma lifts margins as dermatology outperforms despite softer cash flow
TipRanks · 02/22 23:27
Vanguard Group Cuts Stake Below Substantial Holder Threshold in Mayne Pharma
TipRanks · 02/05 21:47
Mayne Pharma Secures Shareholder Backing for Board, Pay and CEO Incentives at AGM
TipRanks · 01/29 04:09
Mayne Pharma Opens Delayed 2025 AGM After Cosette Scheme Setback
TipRanks · 01/29 01:22
Goldman Sachs Ceases to Be Substantial Shareholder in Mayne Pharma
TipRanks · 01/19 08:57
Mayne Pharma to Vigorously Contest Cosette Appeal Over FY25 Metrics
TipRanks · 01/15 05:03
Mayne Pharma Director Frank Condella Steps Down from Board
TipRanks · 01/13 22:57
Mayne Pharma Reshapes Board as Bruce Robinson Appointed Chair
TipRanks · 01/13 22:38
Halvio Capital exits LNF:CA, MAYNF, EDUHF, and NLOP
Seeking Alpha · 01/09 21:50
Mayne Pharma Issues Over 1.09 Million Unquoted Performance Rights Under Employee Scheme
TipRanks · 01/06 05:12
Mayne Pharma Issues New Shares on Conversion of Unquoted Equity Securities
TipRanks · 01/06 05:08
More
Webull provides a variety of real-time MAYNF stock news. You can receive the latest news about Mayne Pharma Group Ltd through multiple platforms. This information may help you make smarter investment decisions.
About MAYNF
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others. Its subsidiaries include Mayne Pharma International Pty Ltd, Mayne Holdings US Inc, Mayne Pharma LLC, and others.